Healthcare

Microfluidics Market Value to Reach US$ 32.97 Bn By 2027 | CAGR 11.5%

Precedence Research recently published a report on “Microfluidics Market (By Material: Glass, Silicon, PDMS, Polymers, and Others; By Technology: Non-Medical and Medical; By Application: Organs-on-chips, Lab-on-a-chip, Continuous Flow Microfluidics, Acoustofluidics and Microfluidics, Optofluidics and Microfluidics, and Electrophoresis and Microfluidics) – Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2020 – 2027”. Amid the COVID-19 crisis, the global microfluidics market size is projected to reach USD 32.97 billion by 2027 from an estimated USD 13.8 billion in 2019, at a CAGR of 11.5% during the forecast period 2020 – 2027.

The market revenue/volume with the help of widespread quantitative and qualitative insights, and forecasts of the market. This report presents breakdown of market into forthcoming and niche segments. Additionally, this research study gauges market revenue growth and its drift at global, regional, and country from 2016 to 2027. This research report evaluates microfluidics market on a global and regional level. It offers thorough analysis of market status, growth and forecast of the global microfluidics market for the period from 2016 to 2027. This research study offers historic data for years 2016 to 2027 along with a forecast from 2020 to 2027 based on value.

Microfluidics refers to the science of controlling and manipulating fluids, commonly in the range of microliters (10-6) to picoliters (10-12), in networks of channels having dimensions ranging from tens to hundreds of micrometers. This discipline was originated in the early 1990’s and since then has been growing exponentially. It is analyzed as an essential tool for the life science research or in other significant researches in the field of biotechnologies. Because of the low volumes required, microfluidic technologies emerged as a promising alternative over the conventional laboratory techniques.

Microfluidics is mostly used and described in “organ on a chip” and “lab on a chip” technologies. However, it can be applied in a wide range of applications that includes pharmaceuticals (drug discovery), cosmetics (emulsions & formulations), chemistry (flow synthesis & stoichiometry), health (personalized medicine & diagnosis), energy (EOR models plasma confinement), and biology (cell culture and 3D printing).

Scope of the Study

This market report studies market dynamics, status and outlook especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This research report offers scenario and forecast (revenue/volume), and categorizes market by players, product, application, and region. This report also studies global market prominence, competitive landscape, market share, growth rate market dynamics such as drivers, restraints and opportunities, and distributors and sales channel.

This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers competitive scenario which comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1116

Growth Factors

Rising demand for Point of Care (POC) testing in a wide range of applications because of the benefits associated with the incorporation of microfluidics along with high return on investments anticipated to propel the market growth of microfluidics during the analysis period. In addition, high-throughput screening methodologies, low-volume sample analysis, and increased demand for in vitro diagnostics (IVD) expected to offer numerous growth opportunities for the players operating in the microfluidics market during the forthcoming years. On the contrary, lack of market visibility for the microfluidics products coupled with high prices of the microfluidics sensors and integrated systems is the key factor that restrict the market growth.

Microfluidics has been successfully applied for the manufacturing of a diverse range of commercial products. For example, integrated fluidic circuits designed by the Fluidigm Corporation offers sample throughput that is comparatively high and provides cost-effective solutions for multiplex single-nucleotide polymorphism genotyping. Likewise, another manufacturer named Quanta Life that provides droplet-based microfluidic solutions for carrying out digital PCR for quantification of nucleic acids.

Caliper Life Sciences offers LabChip systems that use a glass microfluidic chip to receive a high-throughput fluorescent and electrophoretic analysis of protein fragments and nucleic acid. Further, technological advancement is the key factor that drives the market growth. For instance, organ-on-chips are the microfluidic devices that are used for culturing living cells in constantly perfused and micrometer-sized chambers to model physiological functions of tissues and organs.

Report Highlights

  • North America emerged as the largest share holder in the global microfluidics market owing to the presence of well-established market players in the region
  • The Asia Pacific encountered to be the fastest growing market because of affordable labor, sophisticated research infrastructure, and adoption of microfluidic platforms
  • The PDMS-based microfluidic chips segment led the global microfluidics market in terms of revenue in 2019 and expected to register the fastest growth rate over the analysis period
  • Polymer-based microfluidic devices proved as a better alternative to the glass and silicon-based microfluidic devices
  • Based on technology, the medical technology segment dominated the global market in 2019 owing to the major benefits offered by the microfluidics for the POC diagnostics
  • The lab-on-a-chip application accounted for the largest value share in the global market and estimated to continue its dominance throughout the analysis period

Regional Snapshots

North America holds the largest value share in the global market for microfluidics. The growth of the region is mainly attributed to better reimbursement policies, well-established healthcare system, and the higher adoption of novel therapeutics among the common population.

Microfluidics is an enormously growing medical segment particularly in the United States in terms of investment on the Research & Development (R&D) for advancement in the microfluidic devices that further impel the growth of the market value. Further, the field of Point-of-Care (POC) diagnostics largely uses microfluidic technology for wide range of applications such as infectious diseases, molecular diagnostics, resource-limited settings, and chronic diseases. Recent advancements from researchers in the microfluidics aim to produce integrated devices that are automated, self-contained, rapid, and easy-to-use. As the United States has been a front-runner in technological advancements, the microfluidics market in the region expected to flourish at a prominent rate.

Key Players:

This report also provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the microfluidics market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.

Some of the prominent players in the microfluidics market include:

  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Perkinelmer, Inc.
  • Life Technologies Corporation
  • Danaher
  • Bio-Rad Laboratories, Inc.
  • Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Fluidigm Corporation
  • Qiagen N.V.
  • Thermo Fischer Scientific
  • Biomérieux
  • Cellix Ltd.
  • Elveflow
  • Micronit Micro Technologies B.V.

Segments Covered in the Report

This research study comprises complete assessment of the market by means of far-reaching qualitative and quantitative perceptions, and predictions regarding the market. This report delivers classification of marketplace into impending and niche sectors. Further, this research study calculates market size and its development drift at global, regional, and country from 2016 to 2027. This report contains market breakdown and its revenue estimation by classifying iton the basis ofmaterial, technology, application, and region:

By Material

  • Glass
  • Silicon
  • PDMS
  • Polymers
  • Others

By Technology

  • Non-Medical
  • Medical
    • Gel Electrophoresis
    • PCR & RT-PCR
    • ELISA
    • Microarrays
    • Others

By Application

  • Organs-on-chips
  • Lab-on-a-chip
  • Continuous Flow Microfluidics
  • Acoustofluidics and Microfluidics
  • Optofluidics and Microfluidics
  • Electrophoresis and Microfluidics

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Key Takeaways

  • Comprehensive analysis of the microfluidics market trends and shares from 2020 to 2027 at global and regional level to identify growth opportunities and analyze market developments
  • Exhaustive analysis of price trends with respect to resin type and region that are expected to impact the outlook of the global microfluidics market
  • Porters’ Five Forces analysis that highlights the bargaining power of buyers and suppliers to enable stakeholders to make profit-oriented business decisions
  • Extensive market outlook of key geographic regions along with market drivers, inhibitors, current & future market trends, and emerging applications
  • Comprehensive list of key potential clients across major end-use industries in different geographies
  • Thorough import-export analysis  across the globe
  • Regional level production output to comprehend the demand-supply scenario
  • Competitive landscape covers key companies’ profiling, market share analysis, market footprint analysis, competitive business strategies, channels, and competition matrix for key players

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Microfluidics Market, By Material

7.1. Microfluidics Market, by Material Type, 2020-2027
7.1.1. Glass
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Silicon
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. PDMS
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Polymers
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global Microfluidics Market, By Application

8.1. Microfluidics Market, by Application, 2020-2027
8.1.1. Organs-on-chips
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Lab-on-a-chip
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Continuous Flow Microfluidics
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Acoustofluidics and Microfluidics
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Optofluidics and Microfluidics
8.1.5.1. Market Revenue and Forecast (2016-2027)
8.1.6. Electrophoresis and Microfluidics
8.1.6.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Microfluidics Market, By Technology

9.1. Microfluidics Market, by Technology, 2020-2027
9.1.1. Non-Medical
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Medical (Gel Electrophoresis, PCR & RT-PCR, ELISA, Microarrays, Others)
9.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Microfluidics Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Material (2016-2027)
10.1.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.3. Market Revenue and Forecast, by Technology (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Material (2016-2027)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Material (2016-2027)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Material (2016-2027)
10.2.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Material (2016-2027)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Material (2016-2027)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Material (2016-2027)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.6.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Material (2016-2027)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.7.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Material (2016-2027)
10.3.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Material (2016-2027)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Material (2016-2027)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Material (2016-2027)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.6.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Material (2016-2027)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.7.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Material (2016-2027)
10.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Material (2016-2027)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Material (2016-2027)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Material (2016-2027)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.6.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Material (2016-2027)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.7.3. Market Revenue and Forecast, by Technology (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Material (2016-2027)
10.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Material (2016-2027)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Material (2016-2027)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.5.3. Market Revenue and Forecast, by Technology (2016-2027)

Chapter 11. Company Profiles

11.1. Agilent Technologies, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Illumina, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Perkinelmer, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Life Technologies Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Danaher
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Bio-Rad Laboratories, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Hoffmann-La Roche Ltd
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Abbott Laboratories
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Fluidigm Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Qiagen N.V.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Thermo Fischer Scientific
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Biomérieux
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Cellix Ltd.
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Elveflow
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. Micronit Micro Technologies B.V.
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1116

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Recent Posts

test

Read More

December 27, 2021

Drug of Abuse Testing Market Global Sales Are Expected To Reach $ 10.7 Bn by 2030

Precedence Research recently published a report on “Drug of Abuse Testing Market (By Drug Type: Alcohol, Cocaine, Marijuana/Cannabis, LSD, Opioids,… Read More

November 8, 2021

Digital Signage Market Rakes in US$ 38.63 Billion By 2030

Precedence Research recently published a report on “Digital Signage Market (By Component: Hardware, Software, Services; By Technology: LCD, LED, Projection;… Read More

November 8, 2021

Beverage Packaging Market to Grow At Rate of 6.4% Through 2030

Precedence Research recently published a report on “Beverage Packaging Market (By Material: Metal, Plastic, Glass, and Others; By Product: Bottles,… Read More

November 8, 2021

Paper Cups Market Rakes in $ 9.2 Billion By 2030

Precedence Research recently published a report on “Paper Cups Market (By type: Hot Paper Cups and Cold Paper Cups; By… Read More

November 8, 2021

Fire Protection System Market Rakes in $ 116.8 Bn By 2030

Precedence Research recently published a report on “Fire Protection System Market (By Product: Fire Detection, Fire Suppression, Fire Response, Fire… Read More

October 28, 2021

This website uses cookies.